Log in

NASDAQ:BHTG - BioHiTech Global Stock Price, Forecast & News

$1.86
0.00 (0.00 %)
(As of 02/23/2020 04:00 PM ET)
Today's Range
$1.84
Now: $1.86
$1.91
50-Day Range
$1.80
MA: $1.95
$2.14
52-Week Range
$1.54
Now: $1.86
$3.30
Volume48,248 shs
Average Volume35,151 shs
Market Capitalization$32.09 million
P/E RatioN/A
Dividend YieldN/A
Beta2.25
BioHiTech Global, Inc. provides an environmentally friendly solution for food waste disposal. The Company, through its subsidiaries, BioHiTech America, LLC and BioHiTech Europe Limited, offers its customers various technologies integrating technological, biological and mechanical engineering solutions for the control, reduction and/or reuse of organic waste. It has a distribution license to sell, lease, use, distribute and manufacture the Eco-Safe Digester product. The Eco-Safe Digester is a data-driven, network-based mechanical/biological technology, which transforms food waste into nutrient-neutral water that can be disposed of via conventional sanitary sewer systems. The Eco-Safe Digester may be used by businesses in food service, hospitality, healthcare, government, conference centers, education centers or stadiums. Its Internet enabled system, the BioHiTech Cloud, streams data from the digesters, collects information from system users and integrates business application data.

Industry, Sector and Symbol

Industry Educational services
Sub-IndustryN/A
SectorBusiness Services
Current SymbolNASDAQ:BHTG
CUSIPN/A
Phone845-262-1081

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$3.36 million
Book Value$0.37 per share

Profitability

Net Income$-14,670,000.00
Net Margins-193.11%

Miscellaneous

EmployeesN/A
Market Cap$32.09 million
Next Earnings Date4/6/2020 (Estimated)
OptionableNot Optionable

Receive BHTG News and Ratings via Email

Sign-up to receive the latest news and ratings for BHTG and its competitors with MarketBeat's FREE daily newsletter.


BioHiTech Global (NASDAQ:BHTG) Frequently Asked Questions

What is BioHiTech Global's stock symbol?

BioHiTech Global trades on the NASDAQ under the ticker symbol "BHTG."

How were BioHiTech Global's earnings last quarter?

BioHiTech Global Inc (NASDAQ:BHTG) announced its earnings results on Wednesday, August, 14th. The company reported ($0.15) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.05) by $0.10. The business had revenue of $1.05 million for the quarter. BioHiTech Global had a negative return on equity of 176.04% and a negative net margin of 193.11%. View BioHiTech Global's Earnings History.

When is BioHiTech Global's next earnings date?

BioHiTech Global is scheduled to release their next quarterly earnings announcement on Monday, April 6th 2020. View Earnings Estimates for BioHiTech Global.

What guidance has BioHiTech Global issued on next quarter's earnings?

BioHiTech Global issued an update on its FY 2019 Pre-Market earnings guidance on Monday, November, 25th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $$4.8-5 million, compared to the consensus revenue estimate of $$6.06 million.

What price target have analysts set for BHTG?

2 analysts have issued 12 month price targets for BioHiTech Global's shares. Their forecasts range from $3.50 to $5.00. On average, they expect BioHiTech Global's share price to reach $4.25 in the next year. This suggests a possible upside of 128.5% from the stock's current price. View Analyst Price Targets for BioHiTech Global.

What is the consensus analysts' recommendation for BioHiTech Global?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for BioHiTech Global in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for BioHiTech Global.

Has BioHiTech Global been receiving favorable news coverage?

Headlines about BHTG stock have trended somewhat positive this week, according to InfoTrie Sentiment Analysis. The research firm scores the sentiment of news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. BioHiTech Global earned a news impact score of 1.6 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the company's share price in the next several days. View News Stories for BioHiTech Global.

Are investors shorting BioHiTech Global?

BioHiTech Global saw a drop in short interest during the month of January. As of January 31st, there was short interest totalling 27,500 shares, a drop of 7.7% from the January 15th total of 29,800 shares. Based on an average daily trading volume, of 13,900 shares, the short-interest ratio is currently 2.0 days. Currently, 0.3% of the shares of the company are short sold. View BioHiTech Global's Current Options Chain.

Who are some of BioHiTech Global's key competitors?

What other stocks do shareholders of BioHiTech Global own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BioHiTech Global investors own include Opko Health (OPK), NVIDIA (NVDA), Bellicum Pharmaceuticals (BLCM), TransEnterix (TRXC), BIOLASE (BIOL), Citius Pharmaceuticals (CTXR), DISH Network (DISH), ADMA Biologics (ADMA), Allena Pharmaceuticals (ALNA) and Cerecor (CERC).

Who are BioHiTech Global's major shareholders?

BioHiTech Global's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Victory Capital Management Inc. (0.49%), Victory Capital Management Inc. (0.42%) and Cetera Advisor Networks LLC (0.20%). Company insiders that own BioHiTech Global stock include Frank E Celli, James D Chambers and Robert A Joyce. View Institutional Ownership Trends for BioHiTech Global.

Which major investors are selling BioHiTech Global stock?

BHTG stock was sold by a variety of institutional investors in the last quarter, including Victory Capital Management Inc. and Victory Capital Management Inc.. View Insider Buying and Selling for BioHiTech Global.

Which major investors are buying BioHiTech Global stock?

BHTG stock was bought by a variety of institutional investors in the last quarter, including Cetera Advisor Networks LLC. Company insiders that have bought BioHiTech Global stock in the last two years include Frank E Celli, James D Chambers and Robert A Joyce. View Insider Buying and Selling for BioHiTech Global.

How do I buy shares of BioHiTech Global?

Shares of BHTG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is BioHiTech Global's stock price today?

One share of BHTG stock can currently be purchased for approximately $1.86.

How big of a company is BioHiTech Global?

BioHiTech Global has a market capitalization of $32.09 million and generates $3.36 million in revenue each year. View Additional Information About BioHiTech Global.

What is BioHiTech Global's official website?

The official website for BioHiTech Global is http://www.biohitech.com/.

How can I contact BioHiTech Global?

BioHiTech Global's mailing address is 80 RED SCHOOLHOUSE ROAD SUITE 101, CHESTNUT RIDGE NY, 10977. The company can be reached via phone at 845-262-1081 or via email at [email protected]


MarketBeat Community Rating for BioHiTech Global (NASDAQ BHTG)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  120 (Vote Outperform)
Underperform Votes:  123 (Vote Underperform)
Total Votes:  243
MarketBeat's community ratings are surveys of what our community members think about BioHiTech Global and other stocks. Vote "Outperform" if you believe BHTG will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BHTG will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel